A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo

PHASE3CompletedINTERVENTIONAL
Enrollment

462

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG

Silodosin

8 mg daily for 12 weeks

OTHER

Placebo

One capsule daily for 12 weeks

Trial Locations (42)

Unknown

Birmingham

Carmichael

Fresno

Laguna Woods

San Bernardino

Tarzana

Torrance

New Port Richey

Ocala

Orlando

Plantation

Tampa

West Palm Beach

Chicago

Melrose Park

Evansville

Fort Wayne

Overland Park

Greenbelt

Boston

Jackson

Kansas City

Lawrenceville

Voorhees Township

Albuquerque

Albany

Garden City

Kingston

Poughkeepsie

Concord

Cincinnati

Portland

Providence

Mt. Pleasant

Myrtle Beach

Austin

Dallas

San Antonio

Norfolk

Seattle

Tacoma

Madison

Sponsors
All Listed Sponsors
lead

Watson Pharmaceuticals

INDUSTRY

NCT00224120 - A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo | Biotech Hunter | Biotech Hunter